Reinsurance Group of America (RGA)
(Delayed Data from NYSE)
$227.66 USD
+14.70 (6.90%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $227.71 +0.05 (0.02%) 5:08 PM ET
2-Buy of 5 2
A Value C Growth C Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$227.66 USD
+14.70 (6.90%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $227.71 +0.05 (0.02%) 5:08 PM ET
2-Buy of 5 2
A Value C Growth C Momentum A VGM
Zacks News
The Zacks Rank Explained: How to Find Strong Buy Finance Stocks
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
Marsh & McLennan (MMC) Q2 Earnings Beat on Solid Marsh Unit
by Zacks Equity Research
Marsh & McLennan's (MMC) second-quarter results benefit on strong international operations and sound contribution from Health and Wealth businesses.
GoHealth (GOCO) Moves 9.2% Higher: Will This Strength Last?
by Zacks Equity Research
GoHealth (GOCO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
What Makes Reinsurance Group (RGA) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Reinsurance Group (RGA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Reinsurance Group of America, Incorporated (RGA) Hit a 52 Week High, Can the Run Continue?
by Zacks Equity Research
Reinsurance Group (RGA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Is Reinsurance Group of America (RGA) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Best Value Stocks to Buy for July 11th
by Zacks Equity Research
JXN, PK, and RGA made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 11, 2024.
Reasons Why Investors Should Retain Sun Life (SLF) Stock Now
by Zacks Equity Research
Sun Life (SLF) stands to benefit from strategic investments in Asia, strengthening asset management businesses, the scale-up of its U.S. operations and a strong financial position.
Aflac (AFL), SKYGEN Team Up to Enhance Dental and Vision Services
by Zacks Equity Research
Aflac (AFL) joins forces with SKYGEN to improve dental and vision benefit management, boosting customer satisfaction and AFL's product sales through advanced technology and streamlined processes.
Why Reinsurance Group (RGA) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Should Vanguard S&P Mid-Cap 400 Value ETF (IVOV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IVOV
Should You Retain Trupanion (TRUP) Stock in Your Portfolio?
by Zacks Equity Research
Trupanion (TRUP) gains from a focus on pet health and well-being in the pet insurance market. Its solid balance sheet supports investment in new product development and international expansion.
EverQuote (EVER) Rallies 220% in a Year: What's Driving It?
by Zacks Equity Research
EverQuote (EVER) rallies on the back of higher consumer traffic, solid performance of automotive and other insurance marketplace verticals, favorable growth estimates and solid capital position.
Here's Why You Should Hold Brighthouse Financial (BHF) Now
by Zacks Equity Research
Brighthouse Financial (BHF) gains from higher annuity and life insurance sales, conservative investment strategy, improved interest rates and effective capital deployment.
Lincoln National (LNC) Stock Gains 16.4% YTD: Here's Why
by Zacks Equity Research
Lincoln National (LNC) benefits from a robust Group Protection business and improving annuity business.
Primerica (PRI) Stock Rises 15% YTD: Will the Rally Last?
by Zacks Equity Research
Primerica (PRI) is set to grow on a compelling portfolio, strong market presence and a solid capital position.
Here's Why Should You Stay Invested in Manulife (MFC) Stock
by Zacks Equity Research
Manulife (MFC) appears well-poised for growth on its strengthening Asia business, expanding Wealth and Asset Management business, cost savings to improve profitability and solid capital position.
Manulife Financial (MFC) Shares Gain on New Financial Goals
by Zacks Equity Research
Manulife Financial (MFC) sets new financial goals banking on its operational efficiency.
MetLife (MET), GeoBlue Unveil Globaline for Expatriate Benefits
by Zacks Equity Research
MetLife (MET) and GeoBlue launch Globaline, a comprehensive expatriate benefits solution, offering unified medical and ancillary coverage, leveraging extensive global health networks for seamless support.
Want Better Returns? Don?t Ignore These 2 Finance Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Should iShares S&P Mid-Cap 400 Value ETF (IJJ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for IJJ
Should Value Investors Buy Reinsurance Group of America (RGA) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Reinsurance Group (RGA) Up 28.4% YTD: More Room for Growth?
by Zacks Equity Research
Reinsurance Group (RGA) gains from improved pricing, a solid in-force business, an improving interest rate environment, favorable growth estimates and prudent capital deployment.